Full Text View
Tabular View
No Study Results Posted
Related Studies
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
This study is currently recruiting participants.
Verified by Medtronic Spine LLC, September 2007
First Received: September 20, 2007   Last Updated: September 21, 2007   History of Changes
Sponsored by: Medtronic Spine LLC
Information provided by: Medtronic Spine LLC
ClinicalTrials.gov Identifier: NCT00534092
  Purpose

The LTOS is a multi-center longitudinal cohort study of all patients who received the X-STOP device in the Pivotal Trial, Continued Access Protocol (CAP), or Cross-over Study (COS). It is designed to supplement postmarket safety and effectiveness data to be gathered in a Condition of Approval (CoA) study of a population of patients with moderately impaired physical function who elect to undergo X-STOP surgery.


Condition Intervention Phase
Lumbar Spinal Stenosis
Device: X STOP® Interspinous Process Decompression System
Phase IV

MedlinePlus related topics: Spinal Stenosis
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Longitudinal, Defined Population, Retrospective/Prospective Study
Official Title: Long-Term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts

Further study details as provided by Medtronic Spine LLC:

Estimated Enrollment: 75
Study Start Date: December 2006
Estimated Study Completion Date: September 2010
Intervention Details:
    Device: X STOP® Interspinous Process Decompression System
    The X STOP is a titanium implant that fits between the spinous processes of the lumbar spine. It is made from Ti-6AI-4V Eli titanium alloy (ISO 5832/3) and consists of two components: a spacer assembly and a wing assembly.
Detailed Description:

EVALUATE LONG-TERM SAFETY AND EFFECTIVENESS OF THE X STOP INTERSPINOUS PROCESS DECOMPRESSION SYSTEM IN THE PATIENTS WHO RECEIVED THE X STOP UNDER THE IDE. THESE PATIENTS CONSIST OF TWO COHORTS TO BE EVALUATED: PATIENTS WHO HAD MODERATELY IMPAIRED PHYSICAL FUNCTION PRIOR TO X STOP IMPLANTATION (AS DETERMINED BY A BASELINE SCORE >2.0 IN THE PHYSICAL FUNCTINO (PF) DOMAIN OF THE ZURICH CLAUDICATINO QUESTIONNAIRE), AND PATIENTS WHO HAD MILDLY IMPAIRED PHYSICAL FUNCTION PRIOR TO X STOP SURGERY (AS DETERMINED BY A BASELINE SCORE <=2.0 IN THE PF DOMAIN OF THE ZURICH CLAUDICATION QUESTIONNAIRE). PAIN AND FUNCTION EVALUATIONS WILL BE PERFORMED ANNUALLY USING THE ZURICH CLAUDICATION QUESTIONNAIRE (ZCQ), THROUGH THE FIFTH POSTOPERATIVE YEAR. CLINICAL EXAMINATINO WILL BE PERFORMED AT EACH OFFICE VISIT TO CONFIRM THE ABSENCE OF NEUROLOGIC COMPLICATIONS. X-RAY FILMS (AP/LATERAL VIEWS) TAKEN DURING THE FIFTH POSPOPERATIVE YEAR WILLL, BE ANALYZED TO CONFIRM A) MAINTENANCE OF DISTRACTION AND B) THE ABSENCE OF RADIOLOGIC EVIDENCE OF DEVICE-RELATED COMPLICATIONS. SECONDARY ENDPOINTS WILL INCLUDE MEAN SCORES FROM THE SF-36, AND INCIDENCE RATES OF ADVERSE EVENTS, DEVICE FAILURES, AND SECONDARY SURGERIES.

  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

A patient will be admitted into the LTOS program if he/she meets all of the following inclusion criteria:

  1. Completed participation in the Pivotal Trial, CAP, or COS and has the X STOP implant(s) intact at the time of LTOS enrollment; OR is an active CAP/COS participant, has the X STOP implant(s) intact, and has not completed a 24-month follow-up visit in his/her CAP/COS study.
  2. Is willing and able to provide Informed Consent
  3. Is willing and able to return to the clinic for a clinical evaluation or complete study questionnaires without a clinic visit.

Exclusion Criteria:

A patient will not be admitted into the LTOS program if he/she meets any of the following exclusion criteria:

  1. Participated in the Pivotal Trial as part of the X STOP group, but the device has been removed.
  2. Participated in the CAP or COS programs, but the device has been removed.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00534092

Contacts
Contact: Dan Jolivette, MD 408-548-6523 djolivette@kyphone.com
Contact: Connie Rey 408-548-6646 crey@kyphon.com

Locations
United States, California
St. Mary's Spine Center Recruiting
San Francisco, California, United States, 94117
Contact: James F Zucherman, MD     415-750-5835     Zuchermanj@aol.com    
Contact: Flordeliza Yabut, MD     510-828-8809     flormend@hotmail.com    
Principal Investigator: Ken-Yao Hsu, MD            
Principal Investigator: James F Zucherman, MD            
United States, Maine
Neurological & Spine Associates Completed
Scarborough, Maine, United States, 04074
United States, Maryland
Greater Baltimore Spine Care Recruiting
Timonium, Maryland, United States, 21093
Contact: Charles Hartjen, MD     410-683-7260        
Contact: Elizabeth Magee     410-683-7260     emmneuro@yahoo.com    
Principal Investigator: Charles Hartjen, MD            
United States, Virginia
Neurological Specialist Recruiting
Norfolk, Virginia, United States, 23510
Contact: Grant Skidmore, MD     757-625-4455        
Contact: Lee Ann Lamkin, BSN, RN     757-625-4455 ext 27     lalamkin@att.net    
Principal Investigator: Grant Skidmore, MD            
Sponsors and Collaborators
Medtronic Spine LLC
Investigators
Study Director: Dan Jolivette, MD Kyphon, Inc.
  More Information

Publications:
Study ID Numbers: LSS-004-LTO
Study First Received: September 20, 2007
Last Updated: September 21, 2007
ClinicalTrials.gov Identifier: NCT00534092     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Medtronic Spine LLC:
Lumbar Spinal Stenosis
X STOP

Study placed in the following topic categories:
Spinal Diseases
Pathological Conditions, Anatomical
Musculoskeletal Diseases
Constriction, Pathologic
Bone Diseases
Spinal Stenosis

Additional relevant MeSH terms:
Spinal Diseases
Pathological Conditions, Anatomical
Musculoskeletal Diseases
Constriction, Pathologic
Bone Diseases
Spinal Stenosis

ClinicalTrials.gov processed this record on May 07, 2009